The estimated Net Worth of Robert C Koski is at least $916 Thousand dollars as of 29 December 2022. Mr. Koski owns over 79,005 units of Oragenics Inc stock worth over $551,148 and over the last 5 years he sold OGEN stock worth over $364,957. In addition, he makes $0 as Independent Director at Oragenics Inc.
Robert has made over 9 trades of the Oragenics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 79,005 units of OGEN stock worth $8,691 on 29 December 2022.
The largest trade he's ever made was buying 1,000,000 units of Oragenics Inc stock on 30 December 2021 worth over $470,000. On average, Robert trades about 148,056 units every 73 days since 2019. As of 29 December 2022 he still owns at least 1,102,295 units of Oragenics Inc stock.
You can see the complete history of Mr. Koski stock trades at the bottom of the page.
Robert C. Koski is an Independent Director of ORAGENICS, INC. he has served since June 2009. Mr. Koski has practiced as an attorney with the Koski Firm, a sole proprietorship located in Atlanta, Georgia since 1992, where his practice includes litigation and tax law. Mr. Koski has also served as a partner in the Koski Family Limited Partnership, which beneficially owns a controlling interest in the Company, and as a director of the Koski Family Foundation since December 1996. Mr. Koski holds a B.A. degree in Philosophy and English from Colgate University, a JD from Emory School of Law and an LLM degree in Taxation and Litigation from Emory University.
Robert Koski is 56, he's been the Independent Director of Oragenics Inc since 2009. There are 7 older and 1 younger executives at Oragenics Inc. The oldest executive at Oragenics Inc is Dr. Frederick W. Telling Ph.D., 69, who is the Exec. Chairman.
Robert's mailing address filed with the SEC is 4902 EISENHOWER BOULEVARD, , TAMPA, FL, 33634.
Over the last 12 years, insiders at Oragenics Inc have traded over $5,827,684 worth of Oragenics Inc stock and bought 8,095,027 units worth $13,189,855 . The most active insiders traders include Randal Jintrexon Corp Kirk, Joseph Hernandez, and Robert C Koski. On average, Oragenics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $151,398. The most recent stock trade was executed by Fred Telling on 30 November 2023, trading 3,500 units of OGEN stock currently worth $12,495.
oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.
Oragenics Inc executives and other stock owners filed with the SEC include: